Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04596384 · ClinicalTrials.gov registry record · NA
Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery
A NA study of Malignant Solid Neoplasm and Malignant Female Reproductive System Neoplasm, sponsored by City of Hope Medical Center.
- Active
- Registry status
- NA
- Development phase
- 398
- Enrollment target
- 3
- Study locations
NCT04596384: Active NA study of Malignant Solid Neoplasm and Malignant Female Reproductive System Neoplasm, sponsored by City of Hope Medical Center.
NCT04596384 is a NA study of Malignant Solid Neoplasm and Malignant Female Reproductive System Neoplasm that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 398 participants, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (65% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04596384, a NA study of Malignant Solid Neoplasm and Malignant Female Reproductive System Neoplasm, is active but no longer recruiting, sponsored by City of Hope Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 398 participants
- Enrollment target
- 3
- Study locations
Study Summary
This phase III trial compares a home-based telemonitoring program that collects symptom and daily step information to surgeon only care in improving recovery and stopping complications within 30 days after surgery in patients with gastrointestinal, genitourinary, or gynecologic cancer who are scheduled to undergo abdominal surgery. Patients may experience a decrease in functional capacity and experience symptoms like pain and fatigue after surgery, and this may change their ability to walk and function. Home-based telemonitoring of patient symptoms and their ability to walk and function after surgery may help doctors and nurses find and treat problems early, which may improve the patient's recovery and lower the number of complications after surgery.
Primary Outcome
Will calculate percent change from preoperative baseline in daily step count during the first 2 weeks post-discharge from hospital. Will use generalized linear mixed modeling (with treatment and covariates as fixed factors, patient identification as random factor).
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Medical Device Usage and Evaluation
- OTHER Best Practice
- PROCEDURE Functional Assessment
- PROCEDURE Nutritional Assessment
Study Locations (3)
California
- City of Hope Comprehensive Cancer Center - Duarte
- City of Hope Antelope Valley - Lancaster
- City of Hope South Pasadena - South Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 398 participants |
| Start Date | 2021-02-16 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What the registry record for NCT04596384 still lists
NCT04596384 is an interventional study that assigns participants to a tested intervention. The registered 398 participants enrollment target is mid-sized for trials with a published cap, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (65% lower).
The record links to 4 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04596384 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04596384 about?
NCT04596384 is a clinical study titled "Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery". This phase III trial compares a home-based telemonitoring program that collects symptom and daily step information to surgeon only care in improving recovery and stopping complications within 30 days after surgery in patients with gastrointestinal, genitourinary, or gynecologic cancer who are schedu...
What is the current status of trial NCT04596384?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 398 participants. The study started on 2021-02-16. Estimated completion is 2026-11-30.
What conditions does trial NCT04596384 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Malignant Female Reproductive System Neoplasm, Genitourinary System Carcinoma, Digestive System Carcinoma.
What interventions are being tested in trial NCT04596384?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Medical Device Usage and Evaluation (OTHER), Best Practice (OTHER), Functional Assessment (PROCEDURE), Nutritional Assessment (PROCEDURE).
Who is sponsoring clinical trial NCT04596384?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04596384 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04596384's enrollment target sits among peer trials
398 39th of 176 higher than 138 of 176 other Malignant Solid Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
RECRUITING · NA
-
Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy
RECRUITING · NA
-
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting
RECRUITING · NA
-
Community-Based Physical Activity Intervention for Underserved Cancer Survivors
RECRUITING · NA
-
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05365581 · 398 participants · Phase 1
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT00601939 · 397 participants · NA
Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI